A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
Clinical trial NCT06508216 · RECRUITING
Trial details
- NCT number
- NCT06508216
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-05
- Primary completion
- 2025-12-17
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.